ArticleAdvances in hematology2012

JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms.

Mar Bellido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.